Douglas, SD, Rudy, B, Muenz, L, Moscicki, AB, Wilson, CM, Holland, C, Crowley-Nowick, P, Vermund, SH, Friedman, L, Pall, L, Futterman, D, Monte, D, Alovera-DeBellis, M, Hoffman, N, Rudy, B, Schwarz, D, Tanney, M, Belzer, M, Tucker, D, D'Angelo, L, Trexler, C, Townsend-Akpan, C, Hagler, R, Peralta, L, Ryder, G, Miller, S, Feroli, K, Abdalian, SE, Foxworth, D, Green, L, Sturdevant, M, Howell, A
, Flynn, P, Lett, K, Puga, A, Cruz, Henry-Reid, L, Camacho, R, Bell, M, Martinez, J, Johnson, D, Levin, L, Geiger, M, Sawyer, M, Walls, G, Birnbaum, J, Ramnarine, M, Stanford, P, Briggs, F, Holland, C, Moscicki, AB, Murphy, D, Booth, R, Crowley-Nowick, P, Douglas, SD, Wilson, CM, Partlow, C, Hobbs, B, Ellenberg, J, Paolinelli, L, Muenz, L, Myers, T, Sheon, A, Mitchell, R, Rogers, A, Willoughby, A, Davenny, K, Smeriglio, V, Matzen, F, Lew, J & Weissman, G 1999, '
Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents',
AIDS, vol. 13, no. 13, pp. 1629-1635.
https://doi.org/10.1097/00002030-199909100-00005